| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.9% | $6,226,766,199 | 369,576,114 | BlackRock, Inc. | 31 Dec 2024 |
As of 30 Sep 2025, 2 institutional investors reported holding 3,023,620 shares of GSK plc - Common Stock. This represents 0.07% of the company’s total 4,152,540,607 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,023,620 | $64,091,192 | -$2,720,953 | $21.21 | 2 |
| 2025 Q2 | 3,152,006 | $60,038,985 | +$1,307,979 | $19.05 | 1 |
| 2025 Q1 | 3,083,338 | $58,184,947 | -$5,349,963 | $18.87 | 1 |
| 2024 Q4 | 3,366,844 | $56,776,996 | -$1,496,070 | $16.85 | 2 |
| 2024 Q3 | 3,454,929 | $70,278,689 | -$1,369,668 | $20.34 | 2 |
| 2024 Q2 | 3,530,417 | $68,276,093 | -$618,649 | $19.33 | 2 |
| 2024 Q1 | 3,562,405 | $76,837,080 | +$433,136 | $21.58 | 2 |
| 2023 Q4 | 3,542,376 | $65,405,413 | +$2,134,511 | $18.47 | 2 |
| 2023 Q3 | 3,426,777 | $62,371,831 | -$757,680 | $18.20 | 2 |
| 2023 Q2 | 3,468,406 | $61,190,492 | +$7,286,309 | $17.65 | 2 |
| 2023 Q1 | 3,055,459 | $53,866,437 | -$358,145 | $17.63 | 1 |
| 2022 Q4 | 3,075,774 | $53,427,796 | +$5,174,661 | $17.37 | 1 |
| 2022 Q3 | 2,777,875 | $44,475,000 | +$44,475,000 | $16.01 | 1 |